Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Chondrosarcoma × Trabectedin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 3 Ovarian Neoplasms 2 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Osteosarcoma 1 Fanconi Anemia, Complementation Group D1 1 Chondrosarcoma 1 Bone Neoplasms 1

Interventions

spartalizumab 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 envafolimab 1 Trabectedin 1 TQ-B3525 1 Proton Therapy 1 Nivolumab 1 Ipilimumab 1 Heavy Ion Radiotherapy 1 Gelclair 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05131386 2023-03-27

SYNERGIAS

Grupo Espanol de Investigacion en Sarcomas

Phase 2 Unknown

Bone Neoplasms, Chondrosarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡